Concepts (351)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Neoplasms | 45 | 2024 | 631 | 8.750 |
Why?
|
| Spinal Cord Compression | 14 | 2020 | 151 | 5.350 |
Why?
|
| Laser Therapy | 12 | 2021 | 411 | 4.580 |
Why?
|
| Radiosurgery | 27 | 2024 | 1330 | 3.240 |
Why?
|
| Hyperthermia, Induced | 7 | 2021 | 510 | 2.230 |
Why?
|
| Pedicle Screws | 2 | 2023 | 10 | 1.740 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 4 | 2017 | 96 | 1.690 |
Why?
|
| Spinal Fusion | 3 | 2023 | 149 | 1.560 |
Why?
|
| Spinal Fractures | 6 | 2024 | 132 | 1.460 |
Why?
|
| Chordoma | 6 | 2023 | 163 | 1.380 |
Why?
|
| Spinal Diseases | 3 | 2021 | 125 | 1.070 |
Why?
|
| Decompression, Surgical | 5 | 2017 | 143 | 0.970 |
Why?
|
| Benzophenones | 1 | 2023 | 12 | 0.960 |
Why?
|
| Thoracic Vertebrae | 5 | 2020 | 186 | 0.930 |
Why?
|
| Plastics | 1 | 2023 | 93 | 0.890 |
Why?
|
| Chondrosarcoma | 2 | 2023 | 216 | 0.840 |
Why?
|
| Polymers | 1 | 2023 | 223 | 0.840 |
Why?
|
| Neurosurgical Procedures | 8 | 2023 | 609 | 0.800 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2021 | 255 | 0.800 |
Why?
|
| Zygapophyseal Joint | 1 | 2021 | 15 | 0.800 |
Why?
|
| Ganglia, Spinal | 8 | 2023 | 237 | 0.770 |
Why?
|
| Neuralgia | 6 | 2023 | 251 | 0.710 |
Why?
|
| Nociceptors | 4 | 2022 | 86 | 0.630 |
Why?
|
| Thermography | 1 | 2018 | 59 | 0.620 |
Why?
|
| Polymethyl Methacrylate | 1 | 2017 | 41 | 0.610 |
Why?
|
| Neuronavigation | 1 | 2017 | 47 | 0.580 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2023 | 7702 | 0.570 |
Why?
|
| Palliative Care | 3 | 2018 | 2037 | 0.570 |
Why?
|
| Joint Instability | 1 | 2016 | 88 | 0.540 |
Why?
|
| Spine | 5 | 2022 | 293 | 0.530 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2016 | 2326 | 0.470 |
Why?
|
| Meningioma | 4 | 2010 | 289 | 0.470 |
Why?
|
| Lipomatosis | 1 | 2013 | 24 | 0.460 |
Why?
|
| Epidural Space | 1 | 2013 | 42 | 0.460 |
Why?
|
| Remission, Spontaneous | 1 | 2013 | 119 | 0.450 |
Why?
|
| Humans | 89 | 2024 | 261506 | 0.440 |
Why?
|
| Pain Measurement | 7 | 2018 | 953 | 0.430 |
Why?
|
| Trigeminal Neuralgia | 3 | 2012 | 42 | 0.410 |
Why?
|
| Male | 61 | 2023 | 123000 | 0.400 |
Why?
|
| Adult | 44 | 2020 | 77950 | 0.390 |
Why?
|
| Kidney Neoplasms | 3 | 2016 | 3022 | 0.380 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2021 | 852 | 0.370 |
Why?
|
| Treatment Outcome | 22 | 2023 | 32848 | 0.370 |
Why?
|
| Fractures, Compression | 2 | 2024 | 42 | 0.360 |
Why?
|
| Sacrum | 3 | 2023 | 132 | 0.360 |
Why?
|
| Middle Aged | 41 | 2024 | 86204 | 0.360 |
Why?
|
| Neoplasm Recurrence, Local | 9 | 2024 | 10035 | 0.360 |
Why?
|
| Aged | 33 | 2023 | 70117 | 0.350 |
Why?
|
| Female | 52 | 2023 | 141928 | 0.340 |
Why?
|
| Retrospective Studies | 21 | 2024 | 37905 | 0.330 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2021 | 500 | 0.320 |
Why?
|
| Meningeal Neoplasms | 2 | 2003 | 441 | 0.320 |
Why?
|
| Thyroid Neoplasms | 2 | 2016 | 1866 | 0.310 |
Why?
|
| Sensory Receptor Cells | 3 | 2022 | 141 | 0.300 |
Why?
|
| Paclitaxel | 4 | 2021 | 1996 | 0.290 |
Why?
|
| Spinal Cord Diseases | 3 | 2020 | 90 | 0.280 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2017 | 2370 | 0.280 |
Why?
|
| Miosis | 1 | 2005 | 5 | 0.270 |
Why?
|
| Laminectomy | 1 | 2006 | 52 | 0.270 |
Why?
|
| Pain Threshold | 3 | 2017 | 130 | 0.270 |
Why?
|
| Dura Mater | 1 | 2006 | 73 | 0.270 |
Why?
|
| Stereotaxic Techniques | 2 | 2016 | 172 | 0.270 |
Why?
|
| Skull Base Neoplasms | 2 | 2021 | 314 | 0.260 |
Why?
|
| Balloon Occlusion | 1 | 2005 | 49 | 0.260 |
Why?
|
| Osteotomy | 2 | 2020 | 100 | 0.260 |
Why?
|
| Carotid Artery, Internal | 1 | 2005 | 77 | 0.260 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2021 | 393 | 0.260 |
Why?
|
| Blepharoptosis | 1 | 2005 | 70 | 0.260 |
Why?
|
| Aged, 80 and over | 17 | 2019 | 29902 | 0.250 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2003 | 142 | 0.250 |
Why?
|
| Cervical Vertebrae | 3 | 2017 | 205 | 0.250 |
Why?
|
| Intracranial Aneurysm | 1 | 2005 | 123 | 0.240 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 500 | 0.240 |
Why?
|
| Titanium | 1 | 2023 | 61 | 0.230 |
Why?
|
| Ketones | 1 | 2023 | 54 | 0.230 |
Why?
|
| Prosthesis Implantation | 1 | 2006 | 263 | 0.230 |
Why?
|
| Neck Injuries | 1 | 2023 | 32 | 0.220 |
Why?
|
| Mice, Nude | 2 | 2014 | 4307 | 0.220 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 151 | 0.220 |
Why?
|
| Pain Management | 2 | 2018 | 668 | 0.220 |
Why?
|
| Cytodiagnosis | 1 | 2003 | 220 | 0.210 |
Why?
|
| Trigeminal Nerve | 3 | 2012 | 15 | 0.210 |
Why?
|
| Brain Neoplasms | 6 | 2021 | 4849 | 0.210 |
Why?
|
| Transcriptome | 3 | 2023 | 1859 | 0.210 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 7222 | 0.200 |
Why?
|
| Rhizotomy | 1 | 2021 | 13 | 0.200 |
Why?
|
| Fiducial Markers | 1 | 2021 | 96 | 0.190 |
Why?
|
| Ultrasonics | 1 | 2020 | 69 | 0.190 |
Why?
|
| Artifacts | 1 | 2023 | 532 | 0.190 |
Why?
|
| Hyperalgesia | 3 | 2017 | 238 | 0.190 |
Why?
|
| Sarcoma | 2 | 2024 | 1725 | 0.190 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 80 | 0.190 |
Why?
|
| Fractures, Bone | 1 | 2023 | 291 | 0.190 |
Why?
|
| Catheter Ablation | 2 | 2023 | 620 | 0.180 |
Why?
|
| Oncologists | 1 | 2022 | 134 | 0.180 |
Why?
|
| Length of Stay | 2 | 2018 | 1900 | 0.180 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 63 | 0.180 |
Why?
|
| Lipoma | 1 | 2000 | 89 | 0.180 |
Why?
|
| Microsurgery | 1 | 2002 | 244 | 0.180 |
Why?
|
| Polyethylene Glycols | 1 | 2023 | 615 | 0.180 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 245 | 0.180 |
Why?
|
| Corpus Callosum | 1 | 2000 | 138 | 0.180 |
Why?
|
| Migraine Disorders | 4 | 2001 | 79 | 0.180 |
Why?
|
| Digestive System Neoplasms | 1 | 2020 | 82 | 0.180 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 14889 | 0.170 |
Why?
|
| Quality of Life | 3 | 2020 | 4532 | 0.170 |
Why?
|
| Pain, Postoperative | 2 | 2015 | 610 | 0.170 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 75 | 0.170 |
Why?
|
| Survival Rate | 7 | 2017 | 12221 | 0.160 |
Why?
|
| Sarcoidosis | 1 | 2019 | 112 | 0.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 222 | 0.160 |
Why?
|
| Karnofsky Performance Status | 2 | 2016 | 175 | 0.160 |
Why?
|
| NAV1.7 Voltage-Gated Sodium Channel | 1 | 2017 | 5 | 0.160 |
Why?
|
| Postoperative Complications | 4 | 2015 | 5542 | 0.160 |
Why?
|
| RNA | 1 | 2023 | 1013 | 0.150 |
Why?
|
| Kyphosis | 1 | 2017 | 43 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 203 | 0.150 |
Why?
|
| Calcium Channels, T-Type | 1 | 2017 | 27 | 0.150 |
Why?
|
| Fractures, Spontaneous | 1 | 2017 | 84 | 0.150 |
Why?
|
| Prospective Studies | 7 | 2023 | 12873 | 0.140 |
Why?
|
| Skull Base | 1 | 2017 | 199 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2017 | 259 | 0.140 |
Why?
|
| Fluoroscopy | 1 | 2017 | 232 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 7551 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 2138 | 0.130 |
Why?
|
| Paraganglioma | 1 | 2017 | 170 | 0.130 |
Why?
|
| Cubital Tunnel Syndrome | 1 | 2015 | 6 | 0.130 |
Why?
|
| TRPV Cation Channels | 1 | 2015 | 76 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 2024 | 1350 | 0.130 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 3578 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2017 | 239 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.130 |
Why?
|
| Watchful Waiting | 1 | 2017 | 289 | 0.130 |
Why?
|
| Patient Positioning | 1 | 2017 | 195 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 703 | 0.130 |
Why?
|
| Pheochromocytoma | 1 | 2017 | 281 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 925 | 0.120 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 4988 | 0.120 |
Why?
|
| Anesthesia | 1 | 2018 | 296 | 0.120 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 1301 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 2017 | 629 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 4298 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2019 | 1226 | 0.120 |
Why?
|
| Cancer Pain | 1 | 2018 | 312 | 0.120 |
Why?
|
| Risk Factors | 5 | 2023 | 17523 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2018 | 451 | 0.120 |
Why?
|
| Patient Selection | 2 | 2020 | 2055 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2019 | 1529 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2020 | 6207 | 0.110 |
Why?
|
| Graphite | 1 | 2013 | 15 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2021 | 2063 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2017 | 489 | 0.110 |
Why?
|
| Abducens Nerve | 1 | 2012 | 9 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 374 | 0.110 |
Why?
|
| Basilar Artery | 1 | 2012 | 25 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.110 |
Why?
|
| Hemifacial Spasm | 1 | 2012 | 21 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.110 |
Why?
|
| Ependymoma | 1 | 2014 | 242 | 0.100 |
Why?
|
| Prognosis | 8 | 2019 | 21713 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 202 | 0.100 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 11538 | 0.100 |
Why?
|
| Radiotherapy Dosage | 5 | 2018 | 3842 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2017 | 2292 | 0.100 |
Why?
|
| Rats | 5 | 2021 | 6086 | 0.100 |
Why?
|
| Analgesics, Opioid | 2 | 2018 | 1371 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 235 | 0.100 |
Why?
|
| Spinal Nerve Roots | 2 | 2001 | 65 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2023 | 2576 | 0.090 |
Why?
|
| Radiologists | 2 | 2022 | 163 | 0.090 |
Why?
|
| Young Adult | 10 | 2019 | 21445 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 7789 | 0.090 |
Why?
|
| Comorbidity | 2 | 2016 | 2352 | 0.090 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2018 | 2104 | 0.090 |
Why?
|
| Occipital Bone | 2 | 2001 | 23 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 551 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1014 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 598 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2015 | 2307 | 0.090 |
Why?
|
| Cancer Care Facilities | 1 | 2015 | 884 | 0.090 |
Why?
|
| Spinal Cord | 3 | 2020 | 690 | 0.090 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2010 | 52 | 0.090 |
Why?
|
| Spinal Canal | 1 | 2009 | 14 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2017 | 8865 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2018 | 665 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2021 | 2231 | 0.080 |
Why?
|
| Adolescent | 9 | 2017 | 31252 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2016 | 1411 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2023 | 1021 | 0.080 |
Why?
|
| Animals | 9 | 2022 | 59536 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2014 | 929 | 0.070 |
Why?
|
| Action Potentials | 2 | 2022 | 560 | 0.070 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2017 | 163 | 0.070 |
Why?
|
| Odontoid Process | 1 | 2006 | 13 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4557 | 0.070 |
Why?
|
| Arachnoid Cysts | 1 | 2005 | 12 | 0.070 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 1519 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 2 | 2017 | 388 | 0.070 |
Why?
|
| Cerebral Angiography | 1 | 2005 | 129 | 0.060 |
Why?
|
| Clinical Trials, Phase II as Topic | 2 | 2019 | 665 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 2 | 2019 | 604 | 0.060 |
Why?
|
| Rabbits | 1 | 2006 | 957 | 0.060 |
Why?
|
| Random Allocation | 1 | 2006 | 703 | 0.060 |
Why?
|
| Disease Progression | 1 | 2015 | 6682 | 0.060 |
Why?
|
| Cicatrix | 1 | 2006 | 208 | 0.060 |
Why?
|
| Facial Nerve Diseases | 1 | 2003 | 21 | 0.060 |
Why?
|
| Hypertension | 1 | 2013 | 1503 | 0.060 |
Why?
|
| Headache | 2 | 2001 | 163 | 0.060 |
Why?
|
| Ganglioneuroma | 1 | 2003 | 41 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 6009 | 0.060 |
Why?
|
| Hemangioma, Cavernous | 1 | 2003 | 27 | 0.060 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2003 | 49 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2017 | 1391 | 0.050 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2003 | 81 | 0.050 |
Why?
|
| Nerve Block | 2 | 2001 | 176 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2003 | 127 | 0.050 |
Why?
|
| Fibrosis | 1 | 2006 | 793 | 0.050 |
Why?
|
| Incidence | 3 | 2019 | 5673 | 0.050 |
Why?
|
| Child | 6 | 2021 | 29154 | 0.050 |
Why?
|
| Rodentia | 1 | 2022 | 65 | 0.050 |
Why?
|
| Syndrome | 1 | 2005 | 1351 | 0.050 |
Why?
|
| Neurons | 1 | 2013 | 2287 | 0.050 |
Why?
|
| Visually Impaired Persons | 1 | 2001 | 12 | 0.050 |
Why?
|
| Migraine without Aura | 1 | 2001 | 2 | 0.050 |
Why?
|
| Carbamazepine | 1 | 2001 | 49 | 0.050 |
Why?
|
| Angiography | 1 | 2023 | 360 | 0.050 |
Why?
|
| Sarcoma, Myeloid | 1 | 2002 | 95 | 0.050 |
Why?
|
| Trigeminal Nuclei | 1 | 2001 | 2 | 0.050 |
Why?
|
| Photophobia | 1 | 2001 | 10 | 0.050 |
Why?
|
| Temporal Muscle | 1 | 2001 | 5 | 0.050 |
Why?
|
| Blindness | 1 | 2001 | 77 | 0.050 |
Why?
|
| Facial Pain | 1 | 2001 | 20 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2021 | 43 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2001 | 68 | 0.050 |
Why?
|
| Neck Pain | 1 | 2001 | 39 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2021 | 74 | 0.050 |
Why?
|
| Ergotamines | 1 | 2000 | 2 | 0.050 |
Why?
|
| Pressure | 1 | 2001 | 215 | 0.050 |
Why?
|
| Headache Disorders | 1 | 2000 | 6 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2006 | 769 | 0.050 |
Why?
|
| Obesity | 1 | 2013 | 2884 | 0.050 |
Why?
|
| Migraine with Aura | 1 | 2000 | 17 | 0.050 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2000 | 32 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2000 | 52 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 163 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2000 | 162 | 0.050 |
Why?
|
| Tetrabenazine | 1 | 2000 | 41 | 0.050 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2021 | 75 | 0.050 |
Why?
|
| Photic Stimulation | 1 | 2001 | 259 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5319 | 0.040 |
Why?
|
| Logistic Models | 2 | 2019 | 3441 | 0.040 |
Why?
|
| Collagen | 1 | 2003 | 752 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 10001 | 0.040 |
Why?
|
| Sumatriptan | 1 | 1999 | 2 | 0.040 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1999 | 20 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 1323 | 0.040 |
Why?
|
| Cranial Nerves | 1 | 1999 | 20 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2003 | 4744 | 0.040 |
Why?
|
| Osteolysis | 1 | 1999 | 80 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 2003 | 434 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2000 | 242 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 10331 | 0.040 |
Why?
|
| Spider Venoms | 1 | 2017 | 10 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 14551 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 624 | 0.040 |
Why?
|
| Melanoma | 1 | 2015 | 5317 | 0.040 |
Why?
|
| Cell Movement | 1 | 2006 | 2466 | 0.040 |
Why?
|
| Sodium Channel Blockers | 1 | 2017 | 37 | 0.040 |
Why?
|
| Sex Factors | 1 | 2023 | 2139 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 208 | 0.040 |
Why?
|
| Azabicyclo Compounds | 1 | 2017 | 36 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 135 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2003 | 16273 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 409 | 0.030 |
Why?
|
| Time Factors | 4 | 2017 | 12926 | 0.030 |
Why?
|
| Software | 1 | 2023 | 1321 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 9180 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 178 | 0.030 |
Why?
|
| Ulnar Nerve | 1 | 2015 | 21 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2017 | 485 | 0.030 |
Why?
|
| Metastasectomy | 1 | 2017 | 200 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 1945 | 0.030 |
Why?
|
| Photomicrography | 1 | 2014 | 26 | 0.030 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2017 | 304 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 245 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 148 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 833 | 0.030 |
Why?
|
| Radiography | 2 | 2010 | 1904 | 0.030 |
Why?
|
| Vincristine | 1 | 2017 | 1511 | 0.030 |
Why?
|
| Mice | 2 | 2015 | 34495 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 2012 | 30 | 0.030 |
Why?
|
| Microvascular Decompression Surgery | 1 | 2012 | 11 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 3570 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 739 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 7548 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 299 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 733 | 0.030 |
Why?
|
| Benzamides | 1 | 2017 | 1832 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 2450 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1987 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 13658 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 1489 | 0.020 |
Why?
|
| Vacuum | 1 | 2010 | 42 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2015 | 785 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2014 | 629 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3719 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2019 | 5637 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 3001 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 1382 | 0.020 |
Why?
|
| Syringes | 1 | 2010 | 42 | 0.020 |
Why?
|
| Internal Fixators | 1 | 2010 | 14 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 15193 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 1008 | 0.020 |
Why?
|
| Functional Laterality | 2 | 2001 | 316 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2015 | 902 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2014 | 1450 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 915 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 5112 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 1537 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 4758 | 0.020 |
Why?
|
| Craniotomy | 1 | 2010 | 304 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2017 | 1823 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 3045 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 3033 | 0.020 |
Why?
|
| Myelography | 1 | 2005 | 16 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2005 | 56 | 0.020 |
Why?
|
| Fracture Fixation, Internal | 1 | 2006 | 76 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 4053 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 6942 | 0.020 |
Why?
|
| Neurofibroma | 1 | 2003 | 31 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 2003 | 60 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2015 | 9244 | 0.010 |
Why?
|
| Central Nervous System Agents | 1 | 2001 | 20 | 0.010 |
Why?
|
| Ataxia | 1 | 2003 | 176 | 0.010 |
Why?
|
| Brazil | 1 | 2001 | 165 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 2001 | 64 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 2000 | 48 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 7226 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 460 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 1099 | 0.010 |
Why?
|
| Neck | 1 | 2001 | 383 | 0.010 |
Why?
|
| United States | 1 | 2016 | 15433 | 0.010 |
Why?
|
| Dystonia | 1 | 2000 | 163 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 11965 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 1581 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2001 | 2588 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 1819 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 3260 | 0.010 |
Why?
|
| Brain | 1 | 2001 | 4113 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2002 | 6915 | 0.000 |
Why?
|